Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Regular Articles

Increased Fas Expression Reduces the Metastatic Potential of Human Osteosarcoma Cells

Elizabeth A. Lafleur, Nadezhda V. Koshkina, John Stewart, Shu-Fang Jia, Laura L. Worth, Xiaoping Duan and Eugenie S. Kleinerman
Elizabeth A. Lafleur
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadezhda V. Koshkina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Stewart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shu-Fang Jia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura L. Worth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoping Duan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugenie S. Kleinerman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-04-0353 Published December 2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Tranfection of fas into the SAOS-LM7 cell line. A. LM7 cells and LM7 cells stably transfected with fas (LM7-Fas; 2.5 × 105) or a neomycin control plasmid (LM7-neo) were stained with biotinylated antibodies to Fas, treated with streptavidin-phycoerythrin, and analyzed by flow cytometry. B. The above-mentioned cell lines were plated on a 96-well plate in 250 μL of medium and treated as indicated with medium alone (▪), 1 ng/mL Fas antibody (CH11; Embedded Image), or 1 ng/mL IgM isotype control (Embedded Image). After 60 hours, growth inhibition was assayed by [3H]thymidine incorporation.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Effect of fas transfection on the metastatic potential of LM7 cells. Mice received intravenous injection with 1 × 106 LM7 cells, LM7 neo transfectants (LM7-neo), or LM7 fas transfectants (LM7-Fas). The mice were sacrificed 10 weeks later, the lungs were fixed in Bouin’s solution, and the metastases were counted. LM7-Fas cells resulted in fewer nodules compared with LM7 cells (P = 0.0002) and LM7-neo cells (P < 0.0001).

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Fas expression in lung metastases from patients with osteosarcoma. Paraffin-embedded tissue sections were prepared and stained as described in Materials and Methods. Representative slides from patients 1, 8, 13, and 16 are shown. Anti-Fas immunoreactivity is shown as the brown-stained areas, whereas areas that were not reactive to the anti-Fas antibody are indicated by the blue counterstain (hematoxylin). Arrows indicate positive staining for Fas in the patient sample. Human liver was used as a positive control. Original magnification, ×100.

Tables

  • Figures
  • Table 1

    Effect of Fas transfection on the metastatic potential of LM7 cells

    LM77.0/>2005.5/>2006.0/>2005.5/>2006.5/>2009.0/>200
    LM7-neo>0.5/170>0.5/128>0.5/494.0/1212.5/167>0.5/15>0.5/37>0.5/8>0.5/20>0.5/28
    LM7-Fas0/0<0.5/1<0.5/2<0.5/30/0<0.5/20/0<0.5/30/0<0.5/4
    • NOTE. Mice received intravenous injection with 1 × 106 LM7 cells, LM7 neo transfectants (LM7-neo), or LM7 fas transfectants (LM7-Fas). Ten weeks later, the mice were sacrificed, the lungs were fixed in Bouin’s solution, and the metastases were counted and measured. Data represent size (in mm)/number of nodules.

PreviousNext
Back to top
Clinical Cancer Research: 10 (23)
December 2004
Volume 10, Issue 23
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Increased Fas Expression Reduces the Metastatic Potential of Human Osteosarcoma Cells
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Increased Fas Expression Reduces the Metastatic Potential of Human Osteosarcoma Cells
Elizabeth A. Lafleur, Nadezhda V. Koshkina, John Stewart, Shu-Fang Jia, Laura L. Worth, Xiaoping Duan and Eugenie S. Kleinerman
Clin Cancer Res December 1 2004 (10) (23) 8114-8119; DOI: 10.1158/1078-0432.CCR-04-0353

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Increased Fas Expression Reduces the Metastatic Potential of Human Osteosarcoma Cells
Elizabeth A. Lafleur, Nadezhda V. Koshkina, John Stewart, Shu-Fang Jia, Laura L. Worth, Xiaoping Duan and Eugenie S. Kleinerman
Clin Cancer Res December 1 2004 (10) (23) 8114-8119; DOI: 10.1158/1078-0432.CCR-04-0353
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Regular Articles

  • Intermittent Hypoxia Induces Proteasome-Dependent Down-Regulation of Estrogen Receptor α in Human Breast Carcinoma
  • Potent and Specific Antitumor Efficacy of CMC-544, a CD22-Targeted Immunoconjugate of Calicheamicin, against Systemically Disseminated B-Cell Lymphoma
  • Ring Finger Protein 43 as a New Target for Cancer Immunotherapy
Show more Regular Articles

Cancer Biology

  • Expression and Functional Role of CCR9 in Prostate Cancer Cell Migration and Invasion
  • Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis
Show more Cancer Biology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement